Effect of systemic melatonin in periodontal therapy
Phase 4
- Conditions
- Health Condition 1: M278- Other specified diseases of jaws
- Registration Number
- CTRI/2022/12/048262
- Lead Sponsor
- Other self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.systemically healthy Subjects with periodontal disease indicated for flap surgery
2. Subjects with three/two walled intrabony defects that can be regenerated
Exclusion Criteria
1. Subjects without periodontal disease
2. Subjects with periodontal disease not requiring regenerative therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evel of alkaline phosphatase and bone sialoprotein at baseline and 4 weeks after interventionTimepoint: at baseline and 4 weeks after intervention
- Secondary Outcome Measures
Name Time Method Clinical parameters: probing depth, clinical attachment lossTimepoint: Base line, 3 months;Levels of melatoninTimepoint: Baseline, 1 month